PDL BioPharma (PDLI) Q1 Earnings Top Mark, Revenues Rise Y|Y
PDL BioPharma's (PDLI) earnings exceed estimates in the first quarter of 2019. Higher royalty rights as well as product sales lead to a marginal spurt in year-over-year revenues
PDL BioPharma (PDLI) Q1 Earnings Top Mark, Revenues Rise Y|Y
PDL BioPharma's (PDLI) earnings exceed estimates in the first quarter of 2019. Higher royalty rights as well as product sales lead to a marginal spurt in year-over-year revenues